HUMAN`s specials
Single stem cell injection cuts osteoporosis-related fractures by 94%
(Tehran Ana)- A study published in Cell has tested an experimental stem cell therapy for advanced osteoporosis, reporting a 94% reduction in fracture rates over two years following a single injection.
One-time cell injection offers new hope for osteoporosis treatment
(Tehran Ana)- A small clinical trial suggests that a single injection of genetically modified bone marrow cells may help rebuild fragile bones and reduce fractures in older women with advanced osteoporosis.
Russian tuberculosis vaccine enters Phase 3 trials
(Tehran Ana)- Russia’s Gamaleya Research Center has completed Phase 3 clinical trials of a new vaccine designed to prevent tuberculosis infection.
Nanomicellar capsule developed to support liver health
(Tehran Ana)- An Iranian knowledge-based company has developed and launched an oral formulation containing nanomicellar silymarin to help prevent and manage liver diseases and damage.
Study reveals molecular mechanism behind heparin-induced thrombocytopenia
(Tehran Ana)- Researchers at McMaster University have identified a structural mechanism in platelet factor 4 (PF4) that may trigger the harmful immune response underlying heparin-induced thrombocytopenia (HIT).
Prolonged sitting linked to higher cancer risk and mortality
(Tehran Ana)- A new study suggests that prolonged sitting may increase the risk of cancer and cancer-related death, while regular movement could help reduce the risk.
Syrian team patents locally developed device for cancer research
(Tehran Ana)- A Syrian research team has patented a locally developed photodynamic irradiation device for cancer treatment research.
New drug combinations show promise against liver cancer
(Tehran Ana)- A new study using patient-derived “mini-tumors” has identified promising drug combinations that could lead to more effective liver cancer treatments.
Powdered drug developed to prevent kidney stones in children
(Tehran Ana)- Iranian researchers have developed Citrulize-K, a powdered medication designed to prevent kidney stone formation in children by regulating the urinary environment and limiting crystal growth.
Technology-to-Market
